Pharmaceutical Supply Chain Adjustments To Outlast COVID-19

During the coronavirus pandemic, many of us adjusted to the new “normal”. At PCI Pharma Services, we were already in the process of a digital transformation, and the COVID-19 crisis served as an opportunity to accelerate what we had started.

We are looking at the new ways of doing business—digitally and otherwise—and asking ourselves, what changes should we keep for the long term? How can we continue to provide outstanding service to our clients, based on what we have learned?